Promaxo, Inc., a medical imaging, robotics and AI technology company, announced an asset financing agreement with kineo finance, a financing and working capital solutions provider for medical technology, robotics and other high-tech companies. The agreement allows Promaxo to expand its commercial and customer sales programs to include a direct leasing solution.

“We are pleased to add direct leasing as an option to our growing network of physician practices and academic centers. kineo's expertise and understanding of the high-tech medical imaging industry was a key consideration in our decision to partner with them to create a tailored sales-and-lease-back program to benefit our customers,” said Dr. Amit Vohra, founder and CEO of Promaxo. “The financing program supports our growth initiatives, and we look forward to continued market penetration of our platform technology.”

“Promaxo has developed a proprietary system for point of care diagnostic biopsies and treatment of cancers, with a $3 billion addressable market for in-office urology procedures. We welcome the opportunity to support Promaxo as it drives a shift into in-office diagnostic and therapeutic procedures. We look forward to what the future holds for Promaxo,” said Andrew Brigham, President USA at kineo finance.

kineo finance is a Swiss-headquartered asset financing group with subsidiaries in the U.S. and Germany. It provides tailor-made venture leasing and working capital solutions for companies which are starting the commercialization of new products and services with a hardware component. kineo enables young companies to offer their customers product/market-specific "equipment-as-a-service" solutions via pay-per-use, renting or subscription models.